Medical Devices

The UK-based firm's STIMULAN® is now the only EU-certified calcium matrix for combined antibiotic use, revolutionizing bone infection treatment.

A new partnership will integrate data from millions in India and the UAE, aiming to fix research bias and build more equitable AI-driven medicine.

Positive study results for Alvotech's Entyvio biosimilar could disrupt the IBD market, promising lower costs for a blockbuster chronic care treatment.

A new hybrid exhibition model connects global buyers with Asian smart medical innovators for an unprecedented four-month period, signaling a major shift.

iVeena promotes key execs as it prepares for clinical trials of a novel eye drop that could reshape pediatric myopia treatment worldwide.

A simple nasal spray could offer immediate, broad protection against the flu. New landmark studies show how this antibody-based shield could revolutionize prevention.

After a record year in the U.S., Mauna Kea Technologies unveils a new international strategy and leadership model to scale its diagnostic platforms globally.

A breakthrough program at Children's Hospital of Philadelphia is redefining heart pumps as tools for recovery, not just a bridge to transplant.

AIROS Medical's FDA-cleared ARTAIRA device brings non-invasive PAD therapy home as global cases are projected to surge past 360 million by 2050.

Access earns its fourth Best in KLAS award for data archiving, a win that underscores deep customer trust and the critical role of smart data management.

A new smart navigation system for shoulder replacement promises greater accuracy, reduced complications, and better long-term outcomes for patients.

CoSara Diagnostics' ISO 13485 certification paves the way for regulatory approval of a new PCR platform, leveraging India's 'Make in India' initiative.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

Acarix's CADScor®System gains stringent EU MDR certification, a move poised to reshape cardiac diagnostics and fuel the company's expansion in the U.S.

A new biotech partnership is accelerating development of a once-daily tablet for hypoparathyroidism, a rare disease currently requiring injections.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

The global certification giant is betting big on ASEAN's dynamic market, moving from a license model to full control to tap into rising regulatory demands.

Eve Air Mobility secures its first major Asia-Pacific deal with AirX, setting the stage for electric air taxi services in Tokyo and Osaka by 2029.

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.

A new bipartisan law injects vital funds into neuromuscular disease research, a victory driven by years of relentless patient advocacy. Here's what it means.